IP Library Granted Patent US 12,473,522
Granted Patent B2
US 12,473,522 · App. 17/618,823 · Granted Nov 18, 2025

Methods and systems for cell labeling and imaging

Inventors: Alla Zamarayeva (Berkeley, CA); Alexander Alexeev (Atlanta, GA); Todd Sulchek (Atlanta, GA); Sewoon Han (Albany, CA); Miguel Calero-Garcia (San Francisco, CA); Ian Sicher (Alameda, CA)
Assignee: CellFE, Inc.
C12M23/16A61K49/0032A61K49/0043A61K49/0093A61K49/1863A61P35/00C12M35/04B82Y30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,473,522
App. No.
17/618,823
Granted
Nov 18, 2025
Kind
B2
Abstract

The present disclosure provides methods and systems for cell processing, including delivery of imaging agents into cells. The methods and systems may comprise the use of a microfluidic device. The microfluidic device may comprise a channel comprising a compressive element. The compressive element may be configured to reduce a volume of the cell and facilitate the formation of one or more transient pores in a cell membrane of the cell. The one or more pores may permit one or more imaging agents to enter the cell. Also provided are modified cells produced using the disclosed methods and systems and methods of imaging the modified cells in a subject.

Claims (32)

1 . A method for delivering a substance into a cell, comprising:

(a) providing a microfluidic device, wherein:

the microfluidic device comprises a channel that comprises a first wall comprising a first interior surface and a second wall comprising a second interior surface,

the first wall and the second wall extend along a flow direction,

the microfluidic device comprises a compressive element comprising a plurality of ridges connected to the first wall and extending towards the second interior surface,

each of the plurality of ridges comprises a ridge surface that forms a gap with the second interior surface,

each of the plurality of ridges comprises a material having a modulus from 1 to 100 kPa,

each of the plurality of ridges has a rectangular cross-sectional profile in a plane perpendicular to the first interior surface, and

the microfluidic device comprises a fluid within the microfluidic device, wherein the fluid comprises the cell and the substance, and wherein the substance is an imaging agent;

and

(b) subjecting the fluid to flow through the channel in contact with the compressive element, wherein:

a height of the gap is smaller than a diameter of the cell, causing the cell to compress as the cell passes through the gap, and

the contact causes formation of at least one pore in a membrane of the cell, wherein the at least one pore enables an entry of the substance into the cell.

2 . The method of claim 1 , wherein the cell is an animal cell.

3 . The method of claim 1 , wherein the gap between the ridge surface and the second interior surface of the channel is between about 2 μm and about 15 μm.

4 . The method of claim 1 , wherein the cell has a cell diameter, and wherein a gap between the compressive element and an interior surface of the channel is less than or equal to about 20% of the cell diameter.

5 . The method of claim 1 , wherein each of the plurality of ridges has a width of between 15 μm and 250 μm.

6 . The method of claim 1 , wherein the fluid flows through the channel at a rate of from about 100 μL/min to about 1,000 μL/min.

7 . The method of claim 1 , wherein the cell has a volume, and wherein the compressive element is configured to reduce the volume of the cell.

8 . The method of claim 1 , wherein the channel is defined by at least a first wall and a second wall, wherein the first wall and the second wall are substantially rigid.

9 . The method of claim 8 , wherein the first wall comprises a flexible material and a bracing material, and wherein the bracing material is positioned on an exterior surface of the first wall.

10 . The method of claim 8 , wherein the first wall or the second wall is prepared by injection molding.

11 . The method of claim 1 , wherein the channel does not comprise a diversion channel.

12 . The method of claim 11 , wherein the channel is defined by at least a first wall and a second wall, wherein the first wall and the second wall are substantially rigid.

13 . The method of claim 1 , wherein the microfluidic device comprises a sorting element.

14 . The method of claim 1 , wherein the imaging agent is a nanoparticle.

15 . The method of claim 1 , wherein the imaging agent is a magnetic imaging agent.

16 . The method of claim 1 , wherein surface roughness of the ridge surface may be configured to increase cell membrane poration.

17 . The method of claim 1 , wherein the microfluidic device further comprises a recovery space positioned between an adjacent pair of the plurality of ridges.

18 . The method of claim 17 , wherein the recovery space extends between the first wall and the second wall and has a height that is greater than the height of the gap.

19 . The method of claim 17 , wherein the recovery space extends between the first wall and the second wall and has a height that is greater than the diameter.

20 . The method of claim 17 , wherein the recovery space has a length, measured between the adjacent pair of the plurality of ridges, of between 200 μm and 500 μm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2024
From: ZAMARAYEVA, ALLA; ALEXEEV, ALEXANDER; SULCHEK, TODD; HAN, SEWOON; CALERO-GARCIA, MIGUEL; SICHER, IAN
To: CELLFE, INC.
Reel/Frame 067540/0286 →
Continuity (2)
Provisional Application 62860641 · Jun 12, 2019
Related Publication 20220298461A1 · Sep 22, 2022
References Cited (68)
US 6544423B1 · Baurmeister et al. · 2003 [cited by applicant]
US 8356714B2 · Sulchek et al. · 2013 [cited by applicant]
US 10717084B2 · Sulchek et al. · 2020 [cited by applicant]
US 11198127B2 · Sulchek et al. · 2021 [cited by applicant]
US 11268892B2 · Sulchek et al. · 2022 [cited by applicant]
US 20030049833A1 · Chen et al. · 2003 [cited by applicant]
US 20070072290A1 · Hvichia · 2007 [cited by applicant]
US 20110081674A1 · Han et al. · 2011 [cited by applicant]
US 20140227777A1 · Choi et al. · 2014 [cited by applicant]
US 20140248210A1 · Bradbury et al. · 2014 [cited by applicant]
US 20140273229A1 · Meacham et al. · 2014 [cited by applicant]
US 20140287509A1 · Sharei et al. · 2014 [cited by applicant]
US 20150132742A1 · Thuo et al. · 2015 [cited by applicant]
US 20160193605A1 · Sharei et al. · 2016 [cited by applicant]
US 20160272961A1 · Lee · 2016 [cited by applicant]
US 20170233692A1 · Pawell et al. · 2017 [cited by applicant]
US 20170319843A1 · Beebe et al. · 2017 [cited by applicant]
US 20180003696A1 · Sharei et al. · 2018 [cited by applicant]
US 20180016539A1 · Ding et al. · 2018 [cited by applicant]
US 20180142198A1 · Sharei et al. · 2018 [cited by applicant]
US 20180155669A1 · Pawell · 2018 [cited by applicant]
US 20180201889A1 · Sharei et al. · 2018 [cited by applicant]
US 20180245089A1 · Sharei et al. · 2018 [cited by applicant]
US 20180327706A1 · Qin et al. · 2018 [cited by applicant]
US 20190017072A1 · Ditommaso et al. · 2019 [cited by applicant]
US 20190022258A1 · Wei et al. · 2019 [cited by applicant]
US 20190111082A1 · Gilbert et al. · 2019 [cited by applicant]
US 20190177677A1 · Jonas et al. · 2019 [cited by applicant]
US 20190275520A1 · Stewart et al. · 2019 [cited by applicant]
US 20190322976A1 · Williams et al. · 2019 [cited by applicant]
US 20190382796A1 · Gilbert et al. · 2019 [cited by applicant]
US 20200172845A1 · Baker et al. · 2020 [cited by applicant]
US 20200316604A1 · Dadgar · 2020 [cited by applicant]
US 20200332243A1 · Dadgar et al. · 2020 [cited by applicant]
US 20210292700A1 · Han et al. · 2021 [cited by applicant]
US 20210331172A1 · Ito et al. · 2021 [cited by applicant]
US 20210388390A1 · Bernstein et al. · 2021 [cited by applicant]
US 20220105166A1 · Sharei et al. · 2022 [cited by applicant]
US 20220109113A1 · Li et al. · 2022 [cited by applicant]
US 20220168739A1 · Ho · 2022 [cited by examiner]
US 20220204908A1 · Han et al. · 2022 [cited by applicant]
US 20220213422A1 · Zamarayeva et al. · 2022 [cited by applicant]
US 20220298461A1 · Zamarayeva et al. · 2022 [cited by applicant]
WO 2016183482A1 · 2016 [cited by applicant]
WO 2017083391A1 · 2017 [cited by applicant]
WO 2018089497A1 · 2018 [cited by applicant]
WO 2020026047A1 · 2020 [cited by applicant]
WO 2020232418A1 · 2020 [cited by applicant]
WO 2020252215A1 · 2020 [cited by applicant]
U.S. Appl. No. 17/611,454, Non Final Office Action mailed May 1, 2024, 13 pgs. [cited by applicant]
Barber, “A Technic for the Inoculation of Bacteria and Other Substances into Living Cells” The Journal of Infectious Diseases, Apr. 12, 1911, vol. 8, No. 3 (Apr. 12, 1911), pp. 348-360. [cited by applicant]
Deng et al., “Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell Hydroporator” Nano Lett. 2018, 18, 4, 2705-2710. [cited by applicant]
Di Carlo, “Enhanced Velocity Gradients within Microfluidics for Cellular Manipulation” In: Baba, Y., Shoji, S., van den Berg, A. (eds) Micro Total Analysis Systems 2002. Springer, Dordrecht. https://doi.org/10.1007/978-… [cited by applicant]
Ding et al. “High-throughput Nuclear Delivery and Rapid Expression of DNA via Mechanical and Electrical Cell-Membrane Disruption” Nat Biomed Eng. 2017; 1: 0039. [cited by applicant]
Hallow et al., “Shear-induced intracellular loading of cells with molecules by controlled microfluidics” Biotechnol Bioeng. Mar. 1, 2008; 99(4): 846-854. doi: 10.1002/bit.21651. [cited by applicant]
Han et al., “CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation” Science Advances Aug. 14, 2015. [cited by applicant]
International Application Serial No. PCT/US2020/033298, Search Report and Written Opinion mailed Sep. 10, 2020. [cited by applicant]
International Application Serial No. PCT/US2020/037330, Search Report and Written Opinion mailed Jul. 23, 2020. [cited by applicant]
Jarrell et al., “Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding” Sci Rep 9, 3214 (2019). [cited by applicant]
Kang et al., “Intracellular Nanomaterial Delivery via Spiral Hydroporation” (ACS Nano 2020, 14, 3048-3058). [cited by applicant]
Liu et al., “Cell mechanical and physiological behavior in the regime of rapid mechanical compressions that lead to volume change.” Small 16, 1903857-11, 2020. [cited by applicant]
Liu et al., “Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules”, Materials Today 21, 703-712, 2018. [cited by applicant]
Schmiderer et al., “Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws” PNAS Sep. 1, 2020 117 (35) 21267-21273. [cited by applicant]
Sharei et al., “A vector-free microfluidic platform for intracellular delivery” Proc Natl Acad Sci U S A. Feb. 5, 2013; 110(6): 2082-2087. [cited by applicant]
Williams, A.R. et al., “Filtroporation: A Simple, Reliable Technique for Transfection and Macromolecular Loading of Cells in Suspension,” Biotechnology and Bioengineering, vol. 65, No. 3, Nov. 5, 1999. [cited by applicant]
U.S. Appl. No. 17/611,454, Final Office Action mailed Aug. 8, 2024, 10 pgs. [cited by applicant]
DiCarlo et al., “Reagentless mechanical cell lysis by nanoscale barbs in microchannels for sample preparation” Lab on a Chip 3(4):287-91; Aug. 28, 2023. [cited by applicant]
U.S. Appl. No. 17/611,454, Non Final Office Action mailed Jan. 31, 2025, 11 pgs. [cited by applicant]